{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:18:31Z","timestamp":1783660711707,"version":"3.55.0"},"reference-count":64,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>The interest in trials in which activities are being moved to the participants\u2019 direct environment, that is, decentralized, has increased in recent years, but limited research has been conducted into the feasibility and acceptability of such approaches. The Trials@Home RADIAL proof\u2010of\u2010concept (PoC) trial aims to assess the scientific and operational feasibility and quality of a fully decentralized and hybrid trial approach compared to a conventional, site\u2010based approach. RADIAL is a three\u2010arm parallel\u2010group, open\u2010label, multi\u2010center low\u2010intervention phase IV trial conducted in people living with Type 2 diabetes mellitus in six European countries (DE, DK, ES, IT, PL, UK). The RADIAL trial compares three arms with the same clinical intervention (Insulin Glargine 300\u2009U\/mL) but differing degrees of decentralization (the methodological intervention), including online recruitment, remote consenting, remote visits, home\u2010shipment of Investigational Medicinal Product and study materials, home\u2010based biological sample collection, app\u2010reported events\/ePROs, and home\u2010devices for data collection. Key Performance Indicators regarding recruitment, retention, diversity, site satisfaction, participant satisfaction, cost, safety oversight, treatment adherence, and data quality are the main outcomes of the trial. This paper discusses the set\u2010up of RADIAL, describing the design, endpoint selection, and decentralized elements evaluated, as well as discussing insight from RADIAL for future PoC trials. This is the introductory paper in a series of six papers in which we share the lessons learned during set\u2010up, regulatory submission, and conduct of RADIAL. By sharing these insights, we aim to support clinical trial designers, technology developers, and other stakeholders to successfully implement decentralized elements into clinical trials.<\/jats:p>\n                  <jats:p>\n                    This trial was registered with identifier NCT05780151 in\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/jats:ext-link>\n                    and under 2022\u2010500,449\u201026\u201000 in the Clinical Trials Information System (CTIS) clinical trial database.\n                  <\/jats:p>","DOI":"10.1002\/cpt.70025","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:36:14Z","timestamp":1756722974000},"page":"1037-1045","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bringing Trial Activities to Participants\u2014The Trials@Home\n                    <scp>RADIAL<\/scp>\n                    Proof\u2010of\u2010Concept Trial Investigating Decentralization of Trials"],"prefix":"10.1002","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-8243","authenticated-orcid":false,"given":"Mira G.P.","family":"Zuidgeest","sequence":"first","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care University Medical Center Utrecht  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6272-3003","authenticated-orcid":false,"given":"Megan","family":"Heath","sequence":"additional","affiliation":[{"name":"Sanofi  Reading UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-2385","authenticated-orcid":false,"given":"Bart","family":"Lagerwaard","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care University Medical Center Utrecht  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny R.","family":"van Weelij","sequence":"additional","affiliation":[{"name":"Julius Clinical  Zeist The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2037-2461","authenticated-orcid":false,"given":"Linda","family":"Rutgrink","sequence":"additional","affiliation":[{"name":"Sanofi  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-4252","authenticated-orcid":false,"given":"Sten","family":"Hanke","sequence":"additional","affiliation":[{"name":"Institute of eHealth, FH Joanneum University of Applied Sciences  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Vedenkannas","sequence":"additional","affiliation":[{"name":"Bayer Oy  Espoo Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Kosonen","sequence":"additional","affiliation":[{"name":"Bayer Oy  Espoo Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Collamati","sequence":"additional","affiliation":[{"name":"Bayer Spa  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-3658","authenticated-orcid":false,"given":"Jaime","family":"Fons\u2010Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Vaccines Research Area, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO)\u2010Public Health  Valencia Spain"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica, Instituto de Salud Carlos III  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8352-7574","authenticated-orcid":false,"given":"Duco","family":"Veen","sequence":"additional","affiliation":[{"name":"Julius Clinical  Zeist The Netherlands"},{"name":"Optentia Research Programme, North\u2010West University  Potchefstroom South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5623-9684","authenticated-orcid":false,"given":"Helga","family":"Gardarsdottir","sequence":"additional","affiliation":[{"name":"Division Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University  Utrecht The Netherlands"},{"name":"Department of Pharmaceutical Sciences School of Health Sciences, University of Iceland  Reykjavik Iceland"},{"name":"Department of Clinical Pharmacy University Medical Centre Utrecht  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-7127","authenticated-orcid":false,"given":"Isla S.","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"MEMO Research, Division of Cardiovascular Research, School of Medicine University of Dundee  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Dupont","sequence":"additional","affiliation":[{"name":"International Diabetes Federation Europe  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-4468","authenticated-orcid":false,"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care University Medical Center Utrecht  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Trials@Home consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2083"},{"key":"e_1_2_10_2_1","unstructured":"Clinical trials in human medicines<https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/research\u2010development\/clinical\u2010trials\u2010human\u2010medicines>."},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15199"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015276"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.08.001"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774514558307"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.1361"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016216"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3931"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01384-2"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05736-z"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00186-6"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa034"},{"key":"e_1_2_10_14_1","volume-title":"Guideline for Good Clinical Practice E6(R3)","year":"2025"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.4524"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01284-x"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.04.050"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf056"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103520"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.6565"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000500413"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00327-8"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.07.007"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03323-w"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106219"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074334"},{"key":"e_1_2_10_27_1","unstructured":"Recommendation paper on decentralized elements in clinical trials<https:\/\/health.ec.europa.eu\/document\/download\/2ccc46bf\u20102739\u20104b9a\u2010ab6b\u20106f425db78c61_en?filename=mp_decentralized\u2010elements_clinical\u2010trials_rec_en.pdf> (2022). Accessed May 27 2025."},{"key":"e_1_2_10_28_1","unstructured":"Conducting clinical trials with decentralized elements<https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/conducting\u2010clinical\u2010trials\u2010decentralized\u2010elements> (2024). Accessed May 27 2025."},{"key":"e_1_2_10_29_1","unstructured":"Electronic Systems Electronic Records and Electronic Signatures in Clinical Investigations Questions and Answers Guidance for Industry<https:\/\/www.fda.gov\/media\/166215\/download> (2024). Accessed 27 May 2025."},{"key":"e_1_2_10_30_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals For Human Use (ICH).Guideline For Good Clinical Practice E6(R3) Annex 2 \u2013 Draft Version(2025). Geneva Switzerland."},{"key":"e_1_2_10_31_1","unstructured":"The Danish Medicines Agency\u2019s Guidance on the Implementation of Decentralized Elements in Clinical Trials With Medicinal Products<https:\/\/laegemiddelstyrelsen.dk\/en\/news\/2021\/guidance\u2010on\u2010the\u2010implementation\u2010of\u2010decentralized\u2010elements\u2010in\u2010clinical\u2010trials\u2010with\u2010medicinal\u2010products\u2010is\u2010now\u2010available\/~\/media\/5A96356760ED408CBFA9F85784543B53.ashx> (2021). Accessed May 27 2025."},{"key":"e_1_2_10_32_1","unstructured":"Position Paper on decentralized clinical trials (DCTs) with medicinal products in Switzerland 2025<https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/clinical\u2010trials\/clinical\u2010trials\u2010on\u2010medicinal\u2010products\/publikationen.html>. Accessed May 27 2025."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2628"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15003"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.07.011"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70070"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.11.006"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3357"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15205"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441\u2010023\u201000612\u20103"},{"key":"e_1_2_10_41_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063236","article-title":"Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019\u20102020? A cross\u2010sectional study in ClinicalTrials.Gov","volume":"12","author":"Jong A.J.","year":"2022","journal-title":"BMJ Open"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-024-00518-x"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00463-4"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.6786"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013945"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldad022"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00622-9"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.invent.2019.100246"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1441"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70117"},{"key":"e_1_2_10_51_1","doi-asserted-by":"crossref","DOI":"10.1177\/20552076251330519","article-title":"Exploring implementation challenges of decentralized clinical trials: a qualitative study of policy stakeholder perspectives in Denmark","volume":"11","author":"Hestbjerg I.","year":"2025","journal-title":"Digit. Health"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104309"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06706-x"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100339"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199609147.003.0042"},{"key":"e_1_2_10_56_1","unstructured":"Gardarsdottir H.Regulatory interactions and learnings \u2013 RADIAL the trials@home proof\u2010of\u2010concept trial on decentralisation. Submitted for publication in CPT as paper 2 of the RADIAL series."},{"key":"e_1_2_10_57_1","unstructured":"Trials@Home.D4.1 \u2013 Mapping and analysis of the EU legislation on Remote Decentralised Clinical Trials including legal regulatory ethical and stakeholder recommendations for the conduct of the pan\u2010EU pilot<https:\/\/trialsathome.com\/wp\u2010content\/uploads\/2022\/03\/IMI2_Deliverable\u20104.1_WP4_Final_updated\u2010Mar2022.pdf> Accessed May 07 2025."},{"key":"e_1_2_10_58_1","unstructured":"Lipinska.Selecting and preparing clinical sites for the successful conduct of decentralized clinical trial activities. Submitted for publication in CPT as paper 3 of the RADIAL series."},{"key":"e_1_2_10_59_1","volume-title":"RAND\/UCLA Appropriateness Method User\u2019s Manual","author":"Fitch K.","year":"2000"},{"key":"e_1_2_10_60_1","unstructured":"Lagerwaard B.Recruiting and consenting decentralized clinical trial participants \u2013 learnings from the trials@home RADIAL proof\u2010of\u2010concept trial. Submitted for publication in CPT as paper 4 of the RADIAL series."},{"key":"e_1_2_10_61_1","unstructured":"Heath M.Supply of Study Materials and Investigational Medicinal Product to Participants \u2013 Learnings and Challenges from the Trials@Home RADIAL Proof\u2010Of\u2010Concept Trial. Submitted for publication in CPT as paper 5 of the RADIAL series."},{"key":"e_1_2_10_62_1","unstructured":"Hanke S.Operationalizing Decentralized Clinical Trials: Technology Insights and Insights from the Trials@Home RADIAL Proof\u2010of\u2010Concept Trial. Submitted for publication in CPT as paper 6 of the RADIAL series."},{"key":"e_1_2_10_63_1","unstructured":"The Lancet at 200: Video for the Research for Health Spotlight \u2013 The Future of Medical Research<https:\/\/www.thelancet.com\/video\u2010do\/future\u2010medical\u2010research>."},{"key":"e_1_2_10_64_1","unstructured":"ACT EU multi\u2010stakeholder workshop: A patient\u2010centered approach to methodologies. Report of the methodology guidance workshop 23 November 2023https:\/\/accelerating\u2010clinical\u2010trials.europa.eu\/document\/download\/451d68ff\u2010a998\u201043cf\u2010a590\u201045b781c28ff1_en?filename=ACT%20EU%20multi\u2010stakeholder%20workshop%20on%20methodology%20guidance%20%E2%80%93%20report.pdf(2024). Accessed June 03 2025."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:05:57Z","timestamp":1762754757000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/cpt.70025"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70025","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-06-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}